On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

HHS announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.